Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial. [electronic resource]
Producer: 20141022Description: 4-10 p. digitalISSN:- 1536-0075
- Blood Glucose -- metabolism
- Cardiovascular Diseases -- blood
- Cause of Death
- Clinical Trials Data Monitoring Committees
- Clinical Trials as Topic -- ethics
- Codes of Ethics
- Decision Making
- Drug Therapy, Combination
- Ethics Committees, Research
- Ethics, Research
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- administration & dosage
- Informed Consent -- ethics
- Metformin -- administration & dosage
- Moral Obligations
- Mortality -- trends
- Research Personnel -- ethics
- Research Subjects
- Risk
- Sulfonylurea Compounds -- administration & dosage
- Therapeutic Equipoise
- Truth Disclosure -- ethics
- Uncertainty
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.